Search research articles
Contact Us
Filters
Showing results (241-250 of 255) with videos related to
Page
of 26
Sort By:
Frontiers in Cardiovascular Medicine
|
April 24, 2023
Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre "real-world practice" registry-based study
Carlos E Vergara-Uzcategui, Víctor H Moreno, Breda Hennessey, et al.
The Australian and New Zealand Journal of Psychiatry
|
July 16, 2015
A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Ayal Schaffer, Erkki T Isometsä, Jean-Michel Azorin, et al.
Contemporary Clinical Trials Communications
|
September 29, 2020
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design
Iván J Núñez-Gil, Vicente Estrada, Cristina Fernández-Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2018
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
Diwakar Davar, Hong Wang, Joe-Marc Chauvin, et al.
The Australian and New Zealand Journal of Psychiatry
|
July 18, 2015
Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Ayal Schaffer, Erkki T Isometsä, Leonardo Tondo, et al.
Mbio
|
February 11, 2025
Identification of intratumoral bacteria that enhance breast tumor metastasis
Zachary J Gerbec, Antonio Serapio-Palacios, Avril Metcalfe-Roach, et al.
Bipolar Disorders
|
October 21, 2014
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder
Ayal Schaffer, Erkki T Isometsä, Leonardo Tondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
A V Balar, D E Castellano, P Grivas, et al.
ESMO Open
|
May 19, 2026
EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma
J E Rosenberg, P H O'Donnell, D P Petrylak, et al.
ESMO Open
|
August 12, 2025
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
M S van der Heijden, T Powles, S Gupta, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 255) with videos related to
Sort By:
Page
of 26
Frontiers in Cardiovascular Medicine
|
April 24, 2023
Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre "real-world practice" registry-based study
Carlos E Vergara-Uzcategui, Víctor H Moreno, Breda Hennessey, et al.
The Australian and New Zealand Journal of Psychiatry
|
July 16, 2015
A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Ayal Schaffer, Erkki T Isometsä, Jean-Michel Azorin, et al.
Contemporary Clinical Trials Communications
|
September 29, 2020
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design
Iván J Núñez-Gil, Vicente Estrada, Cristina Fernández-Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2018
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
Diwakar Davar, Hong Wang, Joe-Marc Chauvin, et al.
The Australian and New Zealand Journal of Psychiatry
|
July 18, 2015
Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Ayal Schaffer, Erkki T Isometsä, Leonardo Tondo, et al.
Mbio
|
February 11, 2025
Identification of intratumoral bacteria that enhance breast tumor metastasis
Zachary J Gerbec, Antonio Serapio-Palacios, Avril Metcalfe-Roach, et al.
Bipolar Disorders
|
October 21, 2014
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder
Ayal Schaffer, Erkki T Isometsä, Leonardo Tondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2022
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
A V Balar, D E Castellano, P Grivas, et al.
ESMO Open
|
May 19, 2026
EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma
J E Rosenberg, P H O'Donnell, D P Petrylak, et al.
ESMO Open
|
August 12, 2025
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
M S van der Heijden, T Powles, S Gupta, et al.
Page
of 26